Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Flemming

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Biochemical Pharmacology|July 15, 2019
MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cellsChristine C Gana, Kimberley M Hanssen, Denise M T Yu, et al.
Oncotarget|April 11, 2015
MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastomaDiana T Lau, Claudia L Flemming, Samuele Gherardi, et al.
Biochemical Pharmacology|December 22, 2019
CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growthTony Huynh, Jayne Murray, Claudia L Flemming, et al.
Scientific Reports|December 4, 2019
Exploring the microbial biotransformation of extraterrestrial material on nanometer scaleTetyana Milojevic, Denise Kölbl, Ludovic Ferrière, et al.
Oncogene|March 4, 2020
Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibitionAaminah Khan, Emanuele Valli, Hayley Lam, et al.
Biochemical Pharmacology|June 29, 2014
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)Leanna Cheung, Claudia L Flemming, Fujiko Watt, et al.
Cancer Research|May 20, 2016
MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of DyskerinRosemary O'Brien, Sieu L Tran, Michelle F Maritz, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivoJayne Murray, Emanuele Valli, Denise M T Yu, et al.
Journal of the National Cancer Institute|July 30, 2011
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug effluxMichelle J Henderson, Michelle Haber, Antonio Porro, et al.
Science Translational Medicine|February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaLaura D Gamble, Stefania Purgato, Jayne Murray, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Biochemical Pharmacology|July 15, 2019
MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cellsChristine C Gana, Kimberley M Hanssen, Denise M T Yu, et al.
Oncotarget|April 11, 2015
MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastomaDiana T Lau, Claudia L Flemming, Samuele Gherardi, et al.
Biochemical Pharmacology|December 22, 2019
CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growthTony Huynh, Jayne Murray, Claudia L Flemming, et al.
Scientific Reports|December 4, 2019
Exploring the microbial biotransformation of extraterrestrial material on nanometer scaleTetyana Milojevic, Denise Kölbl, Ludovic Ferrière, et al.
Oncogene|March 4, 2020
Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibitionAaminah Khan, Emanuele Valli, Hayley Lam, et al.
Biochemical Pharmacology|June 29, 2014
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)Leanna Cheung, Claudia L Flemming, Fujiko Watt, et al.
Cancer Research|May 20, 2016
MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of DyskerinRosemary O'Brien, Sieu L Tran, Michelle F Maritz, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivoJayne Murray, Emanuele Valli, Denise M T Yu, et al.
Journal of the National Cancer Institute|July 30, 2011
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug effluxMichelle J Henderson, Michelle Haber, Antonio Porro, et al.
Science Translational Medicine|February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaLaura D Gamble, Stefania Purgato, Jayne Murray, et al.
Pageof 4